Furthermore, a higher number of tumor-infiltrated immune cells were present in the combination group, including total CD45+ cells, T-cells, CD8+ T-cells (CD45+ cells PBS VS α4-1BB/AlloDC P=0.0031, AlloDC VS α4-1BB/AlloDC P=0.0315; T-cells PBS VS α4-1BB/AlloDC P=0.0092, AlloDC VS α4-1BB/AlloDC P=0.0127, CD8+ T-cells PBS VS α4-1BB/AlloDC P=0.0022, AlloDC VS α4-1BB P=0.0415) (Figure 2F). This evidence concerns the gene PTPRC and neoplasm.